current
urgent
unmet
need
increas
coronaviru
diseas
test
capabl
effect
respond
pandem
howev
current
shortag
rna
extract
reagent
well
limit
qpcr
protocol
result
bottleneck
test
capac
herein
describ
novel
molecular
diagnost
base
sanger
sequenc
assay
use
addit
frameshift
spikein
modifi
pcr
master
mix
custom
sanger
sequenc
data
analysi
detect
quantifi
rna
limit
detect
compar
exist
qpcrbase
assay
genom
copi
equival
crucial
assay
abl
detect
rna
viral
particl
suspend
transport
media
directli
ad
pcr
master
mix
suggest
rna
extract
skip
entir
without
degrad
test
perform
sinc
sanger
sequenc
instrument
widespread
clinic
laboratori
commonli
builtin
liquid
handl
autom
support
sampl
per
instrument
per
day
widespread
adopt
qsanger
diagnost
unlock
test
per
day
us
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
public
health
emerg
intern
concern
viru
first
emerg
wuhan
china
decemb
spread
countri
april
million
individu
infect
death
report
one
studi
found
undocu
infect
infect
sourc
document
case
evid
report
suggest
asymptomat
minim
symptomat
patient
high
level
viral
shed
substanti
undocu
infect
along
nonspecif
clinic
featur
uncertainti
transmiss
virul
present
signific
challeng
contain
viru
effect
vaccin
treatment
avail
rapid
accur
wide
avail
diagnost
test
symptomat
patient
also
come
contact
posit
case
critic
curb
spread
viru
howev
test
limit
suppli
us
mani
countri
world
backbon
diagnosi
quantit
polymeras
chain
reaction
qpcr
test
limit
number
qpcr
machin
limit
qpcr
protocol
safe
stop
point
readili
automat
process
hamper
largescal
test
furthermor
sensit
qpcr
requir
specif
rna
extract
reagent
current
short
suppli
diagnost
includ
bloodbas
immunoassay
often
less
accur
molecular
assay
indirectli
detect
immun
respons
symptom
appear
crisprbas
assay
still
develop
report
describ
molecular
diagnost
method
base
quantit
sanger
qsanger
techniqu
reconstruct
quantit
data
sanger
sequenc
chromatogram
origin
develop
valid
noninvas
prenat
test
nipt
cellfre
dna
cfdna
workflow
qsangerbas
highli
similar
tradit
sanger
sequenc
revers
transcript
rt
pcr
amplicon
fig
includ
addit
frameshift
synthet
spikein
dna
reaction
master
mix
qsanger
design
support
onestep
reversetranscript
rt
pcr
directli
viral
transport
media
vtm
specimen
without
rna
purif
step
fig
amplif
product
purifi
sanger
sequenc
autom
capillari
electrophoresi
synthet
dna
includ
rtpcr
master
mix
prior
pcr
amplif
serv
intern
control
enabl
specimen
readili
identifi
either
posit
neg
fig
quantit
analysi
sanger
sequenc
chromatogram
give
qsanger
extrem
high
sensit
specif
posit
result
limit
detect
genom
copi
equival
gce
equival
goldstandard
qpcr
method
furthermor
presenc
spikein
intrasampl
control
qsanger
assay
allow
easi
interpret
result
determin
sourc
error
eg
extract
amplif
sequenc
failur
also
allow
populationlevel
analys
mutat
analysi
contact
trace
addit
ratio
amplitud
correspond
base
endogen
spikein
sequenc
offset
posit
reflect
ratio
molecular
abund
two
sequenc
comput
combin
amplitud
ratio
multipl
correspond
base
use
estim
viral
load
dynam
rang
poissonlimit
coeffici
variat
initi
demonstr
qualit
detect
qsanger
design
pcr
primer
synthet
dna
spikein
target
n
protein
fig
onestep
rtpcr
mix
neb
contain
use
perform
reversetranscript
rna
subsequ
pcr
amplif
one
pot
rtpcr
ad
either
nucleasefre
water
notempl
control
ntc
gce
synthet
rna
twist
bioscienc
reaction
also
gce
spikein
rtpcr
master
mix
rtpcr
sanger
sequenc
observ
qualit
clean
chromatogram
spikein
sequenc
ntc
condit
rna
ad
fig
gce
level
sanger
chromatogram
show
clear
mix
base
correspond
approxim
equal
abund
spikein
dna
rna
gce
rna
chromatogram
exhibit
rel
pure
trace
target
sequenc
suggest
signal
overwhelm
spikein
signal
present
greater
abund
determin
limit
detect
qsanger
perform
assay
dilut
rna
correspond
gce
gce
gce
gce
gce
four
replic
dilut
assay
qsanger
qpcr
expect
replic
gce
neg
qpcr
addit
gce
exhibit
clear
logarithm
decreas
qpcr
cycl
threshold
ct
fig
similarli
sequenc
appar
sanger
chromatogram
ntc
condit
spikein
sequenc
qualit
discern
gce
dilut
mix
base
obvious
present
gce
gce
condit
suggest
limit
detect
gce
develop
custom
bioinformat
analys
extract
rel
abund
spikein
amplifi
product
sanger
chromatogram
autom
analysi
qsanger
chromatogram
see
method
briefli
peak
amplitud
assign
either
spikein
sequenc
base
posit
linear
regress
analysi
perform
determin
qsanger
ratio
spikein
trace
intens
qsanger
ratio
near
recov
sampl
gce
indic
complet
absenc
rna
fig
sinc
rna
gce
qsanger
ratio
greater
provid
evid
limit
detect
qsanger
gce
fewer
quantit
analysi
chromatogram
peak
height
abl
recov
qsanger
ratio
even
gce
condit
qsanger
ratio
excel
linear
gce
fig
furthermor
qsanger
ratio
good
agreement
qpcr
ct
valu
fig
qsanger
detect
rna
amplifi
directli
viral
particl
transport
medium
without
rna
purif
sinc
major
limit
increas
test
capac
suppli
chain
lab
workflow
bottleneck
relat
rna
extract
next
attempt
detect
directli
specimen
matrix
viral
transport
medium
previou
report
rtqpcr
success
perform
total
reaction
volum
vtm
without
extract
use
templat
rtpcr
hypothes
qsanger
could
reliabl
method
detect
without
rna
extract
increas
robust
pcr
inhibitor
specimen
matrix
sinc
quantif
perform
via
comparison
spikein
intern
control
ii
improv
limit
detect
ad
vtm
correspondingli
larger
reaction
size
iii
avoid
falseposit
examin
sequenc
data
correct
spikein
sequenc
test
hypothesi
obtain
refer
materi
either
posit
control
human
rna
neg
control
packag
insid
viral
particl
suspend
vtm
seracar
sinc
polymeras
mix
vari
resili
pcr
inhibitor
also
evalu
luna
rtqpcr
onetaq
rtpcr
kit
seracar
neg
posit
control
specimen
eight
replic
perform
crossproduct
condit
luna
vs
onetaq
polymeras
direct
vtm
vs
purifi
rna
reaction
total
seracar
specimen
correspond
gce
ad
total
reaction
volum
addit
replic
notempl
control
perform
polymeras
wherein
nucleas
free
water
ad
reaction
ntc
sampl
across
condit
neg
qsanger
assay
analysi
fig
nearli
seracar
neg
control
sampl
determin
neg
qsanger
indetermin
result
obtain
purifi
rna
luna
specimen
purifi
onetaq
specimen
seracar
posit
control
identifi
qsanger
except
onetaq
direct
vtm
specimen
fig
sampl
classifi
undetermin
due
low
chromatogram
signal
intens
signal
nois
ratio
lack
sequenc
align
possibl
reason
undetermin
chromatogram
could
failur
rna
extract
pcr
amplif
cycl
sequenc
sinc
major
undetermin
specimen
use
purifi
rna
possibl
major
assay
failur
due
rna
extract
process
perhap
carryov
high
salt
buffer
consid
evalu
feasibl
direct
vtm
extractionfre
method
detect
also
examin
abil
qsanger
quantifi
amount
viral
particl
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
seracar
posit
control
specimen
fig
sinc
reaction
contain
gce
gce
spikein
expect
measur
qsanger
ratio
onetaq
result
yield
qsanger
ratio
consist
around
discrep
could
due
slightli
effici
amplif
sequenc
compar
spikein
sequenc
remark
luna
polymeras
mix
yield
qsanger
ratio
sem
vtm
qsanger
ratio
sem
purifi
rna
close
expect
ratio
differ
par
typic
imprecis
pipet
dna
quantif
coeffici
variat
cv
vtm
rna
purifi
luna
assay
respect
notabl
good
agreement
imprecis
associ
molecul
poisson
limit
sinc
luna
exhibit
better
accuraci
precis
compar
onetaq
luna
direct
vtm
method
result
correct
call
ntc
seracar
posit
neg
specimen
without
fail
reaction
subsequ
experi
perform
luna
polymeras
mix
final
sought
demonstr
omit
rna
extract
advers
affect
qsanger
sensit
ad
gce
correspond
lod
fig
viral
particl
vtm
contain
either
neg
control
rna
fig
sanger
chromatogram
clearli
show
absenc
presenc
signal
neg
posit
control
respect
fig
qsanger
assay
correctli
identifi
neg
posit
sampl
sampl
test
neg
control
specimen
return
undetermin
result
due
sequenc
failur
fig
overal
excel
perform
shown
qsanger
result
unextract
vtm
vs
purifi
rna
respect
absolut
quantif
accuraci
poissonlimit
coeffici
variat
limit
detect
compar
goldstandard
rtqpcr
suggest
qsanger
perform
unprocess
specimen
matrix
without
loss
perform
fact
might
possibl
rnaextract
free
method
reliabl
elimin
carryov
risk
highsalt
pcrinhibit
buffer
use
rna
extract
procedur
pandem
one
deadli
disrupt
public
health
emerg
face
last
hundr
year
curb
rapid
spread
countri
issu
shelterinplac
rule
abl
flatten
pandem
curv
signific
econom
cost
social
distanc
intervent
relax
vaccin
develop
estim
take
month
develop
wide
distribut
widespread
rapid
test
perform
symptomat
patient
well
anyon
identifi
like
come
contact
test
posit
suggest
effect
contact
trace
addit
peopl
may
need
test
posit
case
howev
april
us
daili
test
capac
test
patient
test
posit
suggest
us
test
capac
might
need
increas
factor
effect
contact
trace
howev
test
current
avail
reli
variat
qpcr
thu
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
suffer
suppli
chain
issu
particular
limit
avail
rna
extract
kit
import
problem
increas
test
capac
describ
novel
quantit
sanger
qsanger
assay
detect
without
rna
extract
show
qsanger
perform
well
qpcr
estim
viral
rna
abund
consist
detect
low
viral
genom
copi
equival
even
vtm
ad
directli
reaction
mix
without
rna
extract
qsanger
endpoint
pcr
reaction
intern
spikein
control
robust
inhibitor
exist
vtm
failur
amplif
result
undetermin
result
requir
repeat
reaction
oppos
fals
neg
would
obtain
qpcr
also
higher
specif
qpcr
examin
sequenc
inform
use
distinguish
similar
virus
rule
falseposit
due
nonspecif
amplif
sinc
qsanger
extrem
high
specif
enabl
sequenc
inform
use
routin
test
asymptomat
individu
high
posit
predict
valu
ppv
new
paradigm
routin
repeat
test
individu
high
risk
contract
diseas
eg
hospit
staff
older
comorbid
earli
detect
improv
individu
healthcar
outcom
also
enabl
relax
popul
scale
nonpharmaceut
intervent
like
social
distanc
measur
addit
requir
rna
extract
kit
qsangerbas
assay
number
addit
advantag
compar
exist
qpcrbase
test
importantli
qsanger
thermal
cycl
occur
higherthroughput
endpoint
pcr
instrument
rather
special
qpcr
instrument
sequenc
run
autom
sanger
sequenc
plate
feeder
appli
biosystem
dna
analyz
capac
sequenc
sampl
per
day
larg
exist
installbas
endpoint
pcr
highthroughput
sanger
instrument
throughout
us
world
support
rapid
scaleup
assay
without
requir
new
devic
instrument
manufactur
given
sanger
sequenc
still
wide
use
method
clinic
sequenc
worldwid
widespread
adopt
assay
describ
creat
test
capac
per
day
broadli
qsanger
enabl
even
higher
volum
populationscal
test
clinic
laboratori
sanger
sequenc
center
allow
collabor
test
sanger
sequenc
exist
molecular
diagnost
laboratori
commonli
util
high
volum
genom
center
academ
sequenc
core
facil
commerci
sanger
sequenc
servic
laboratori
model
clinic
laboratori
could
buy
mastermix
reaction
plate
simpli
requir
addit
patient
sampl
reaction
well
biosafeti
cabinet
pcr
thermocycl
wherea
sequenc
servic
laboratori
would
sequenc
sampl
nextday
result
would
enabl
rapidli
deploy
distribut
populationscal
test
qsanger
also
number
advantag
may
prove
invalu
learn
inform
sinc
mutat
quickli
avail
sequenc
inform
use
identifi
grow
cluster
mutat
aid
contact
trace
via
phylogenet
analysi
mutat
data
longer
sequenc
design
captur
wide
rang
mutat
qsanger
reaction
viru
mutat
creat
substrain
differ
clinic
implic
moreov
oppos
rel
measur
obtain
qpcr
absolut
measur
viral
load
obtain
qsanger
due
known
molecular
count
spikein
quantif
viral
abund
sampl
may
prove
use
determin
infecti
well
accur
environment
monitor
quantit
dynam
rang
qsanger
broaden
gce
gce
employ
two
qsanger
reaction
differ
molecular
level
spikein
time
human
genom
project
sanger
instrument
autom
stateoftheart
devic
gener
sequenc
inform
singl
day
entir
laboratori
could
produc
year
acceler
releas
first
human
genom
five
year
usher
era
exponenti
decreas
sequenc
cost
qsanger
method
present
repurpos
enabl
million
diagnost
need
suppress
global
pandem
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
primer
spikein
spikein
sequenc
design
use
viral
genom
region
correspond
cdc
design
qpcr
assay
spikein
molecul
sequenc
ident
sequenc
includ
base
posit
lack
base
primer
flank
delet
use
amplif
sequenc
perform
use
primer
contain
forward
amplif
bind
region
purpos
sequenc
synthet
genom
rna
twist
bioscienc
use
rna
detect
linear
experi
accuplex
refer
materi
kit
manufactur
seracar
cat
use
proxi
clinic
sampl
viral
purif
perform
use
purelink
viral
rnadna
mini
kit
thermofish
scientif
use
gceml
accuplex
posit
neg
sampl
gce
input
estim
purifi
rna
estim
correspond
fraction
eluent
assum
recoveri
qpcr
perform
use
primer
taqman
probe
provid
ruo
kit
manufactur
idt
cat
amplif
perform
describ
cdc
eua
protocol
briefli
synthet
rna
templat
dilut
rnasefre
te
ad
reaction
rna
sampl
combin
water
taqpath
rtqpcr
master
mix
primer
final
concentr
nm
probe
total
final
volum
reaction
mixtur
amplifi
probe
fluoresc
detect
use
mastercycl
ep
realplex
realtim
pcr
system
first
cycl
threshold
estim
ct
perform
default
set
use
realplex
softwar
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
qsanger
amplif
revers
transcript
amplif
figur
perform
use
onetaq
onestep
rtpcr
kit
neb
cat
onetaq
onestep
rtpcr
kit
luna
univers
onestep
rtqpcr
kit
cat
use
figur
figur
perform
exclus
luna
univers
onestep
rtqpcr
kit
buffer
enzym
use
accord
manufactur
recommend
total
volum
reaction
contain
final
concentr
vv
nm
final
concentr
amplif
primer
gce
synthet
dsdna
spikein
molecul
synthet
rna
sampl
ad
synthet
sampl
ad
achiev
appropri
number
viral
particl
thermocycl
perform
use
appli
biosystem
veriti
thermal
cycler
follow
cycl
program
concord
call
sanger
sequenc
analyz
use
follow
procedur
primari
base
sequenc
base
automat
call
align
viral
genom
align
sequenc
match
viral
genom
sequenc
without
delet
sampl
call
posit
viral
rna
sequenc
match
refer
signal
nois
ratio
check
less
indic
insuffici
signal
return
indetermin
result
signal
nois
greater
ratio
genom
sequenc
spikein
sequenc
quantifi
perform
robust
linear
regress
genom
peak
height
spikein
peak
height
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
quantit
figur
perform
qualiti
check
quantifi
termin
base
refer
spikein
sequenc
primari
sequenc
regardless
whether
genom
spikein
mix
sequenc
domin
analysi
perform
use
custom
script
r
employ
seqinr
tidyvers
packag
reversetranscript
rt
pcr
amplif
target
region
accomplish
directli
addit
viral
transport
media
vtm
onestep
rtpcr
master
mix
copi
synthet
spikein
dna
target
region
spikein
dna
coamplifi
standard
thermal
cycler
amplif
product
sanger
sequenc
custom
data
analysi
result
chromatogram
use
determin
whether
specimen
neg
posit
b
synthet
spikein
design
sequenc
homolog
target
coamplifi
target
pair
bp
delet
spikein
design
enabl
quantif
rel
abund
spikein
dna
sanger
sequenc
chromatogram
depict
forward
revers
primer
scale
c
repres
sanger
sequenc
trace
show
pure
genom
sequenc
top
pure
spikein
sequenc
middl
sequenc
mixtur
genom
spikein
sequenc
bottom
spikein
use
offset
compar
wild
type
wt
mean
two
sequenc
present
signal
sequenc
use
estim
rel
abund
see
arrow
exampl
pair
base
qsanger
quantit
approach
measur
viral
abund
sampl
data
analysi
interpret
qsanger
assay
repres
sanger
sequenc
chromatogram
shown
amplifi
product
spikein
dna
rna
mixtur
two
sinc
spikein
intern
control
amplif
sequenc
observ
spikein
signal
indic
rna
absent
therefor
specimen
neg
contrast
observ
signal
indic
rna
abund
specimen
quantifi
rang
mix
chromatogram
spikein
abund
rna
determin
rel
contribut
spikein
signal
intens
b
synthet
viral
genom
rna
ad
rtpcr
reaction
gce
dilut
subject
qsanger
test
rtqpcr
b
rtqpcr
exhibit
linear
estim
across
dilut
seri
consist
previou
result
c
across
dilut
seri
ratio
r
genom
sequenc
spikein
sequenc
scale
rna
ad
qpcr
estim
abund
compar
qsanger
estim
abund
exhibit
strong
linear
relationship
indic
qsanger
perform
well
qpcr
estim
viral
rna
abund
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
figur
qsanger
detect
rna
amplifi
directli
viral
particl
transport
medium
total
notempl
control
neg
control
sampl
seracar
posit
sampl
seracar
assay
result
concord
seracar
ntc
three
sampl
nocal
undetermin
due
low
signaltonois
ratio
sequenc
result
b
posit
seracar
sampl
ad
rtpcr
master
mix
either
directli
vtm
purif
rna
extract
kit
gce
ratio
refer
spikein
intens
measur
custom
data
analysi
mean
qsanger
ratio
sem
direct
addit
sem
purifi
coeffici
variat
cv
posit
seracar
sampl
measur
luna
onetaq
polymeras
mix
cv
luna
direct
vtm
luna
purifi
consist
theoret
count
nois
associ
quantifi
molecul
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
figur
qsanger
detect
littl
gce
without
rna
purif
repres
sanger
sequenc
trace
neg
control
viru
left
sequenc
contain
viru
right
even
signal
low
detect
mix
base
offset
caus
delet
spikein
compar
genom
sequenc
identifi
posit
sampl
sequenc
peak
identifi
inset
correspond
spikein
sequenc
offset
bp
see
pair
arrow
b
twenti
sampl
neg
control
viru
sequenc
contain
viru
directli
ad
rtpcr
master
mix
spikein
molecul
sanger
sequenc
perform
sampl
success
sequenc
accur
identifi
one
neg
sampl
undetermin
due
sequenc
failur
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
